Efficacy of a feed additive consisting of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) for ruminants (Mazzoleni S.p.A.)
Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Maryline Kouba, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Roberto Edoardo Villa

TL;DR
This study evaluates the effectiveness of a yeast-based feed additive for improving performance in ruminants like veal calves and dairy cows.
Contribution
The study confirms the efficacy of BioCell® for all ruminants based on new trials in veal calves and prior data.
Findings
Supplementation with BioCell® improved performance in veal calves at 1.7 × 109 CFU/kg feed.
The additive is effective for dairy ruminants at 4.0 × 108 CFU/kg feed.
BioCell® is efficacious for ruminants for fattening and rearing at 4.0 × 109 CFU/kg feed.
Abstract
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) as a zootechnical feed additive for horses, pigs and ruminants. In a previous opinion, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive has the potential to be efficacious at the proposed conditions of use for horses, dairy ruminants and all pigs. However, the Panel was not in the position to conclude on the efficacy of BioCell® for calves, and, consequently, for other ruminants for fattening or rearing. The applicant provided three additional efficacy trials in veal calves to support the efficacy of BioCell® for ruminants for fattening or rearing. The three studies showed positive effects of the supplementation with the additive at 1.7 × 109 colony forming…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
|
| Zootechnical additives |
|
| Digestibility enhancers |
|
|
|
|
| For horses, pigs and ruminants |
|
| Mazzoleni S.p.A. |
|
| New opinion |
| Trial | Total no of animals (animals × replicate) replicates × treatment |
Breed Sex (duration) | Feeding regime (composition) | Groups (CFU/kg solid feed) | ||
|---|---|---|---|---|---|---|
| Intended | Analysed1 | Calculated2 | ||||
|
|
■■■■■ ■■■■■ ■■■■■ |
■■■■■ ■■■■■ ■■■■■ | ■■■■■ |
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
|
|
■■■■■ ■■■■■ ■■■■■ |
■■■■■ ■■■■■ ■■■■■ | ■■■■■ |
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
|
|
■■■■■ ■■■■■ ■■■■■ |
■■■■■ ■■■■■ ■■■■■ | ■■■■■ |
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
| Trial | Groups (CFU/kg solid feed) | Total dry matter intake (kg) | Initial body weight (kg) | Final body weight (kg) | Average daily weight gain (kg) | Feed‐to‐gain ratio | Mortality and culling (%) |
|---|---|---|---|---|---|---|---|
|
|
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
|
|
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
|
|
0 4.0 × 109 |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
■■■■■ ■■■■■ |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAgricultural safety and regulations · Genetically Modified Organisms Research
INTRODUCTION
1
Background and Terms of Reference as provided by the requestor
1.1
Regulation (EC) No 1831/2003 establishes the rules governing the Community authorisation of additives for use in animal nutrition and, in particular, Article 9 defines the terms of the authorisation by the Commission.
The applicant, Mazzoleni S.p.A.,1 is seeking a Community authorisation of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) as a zootechnical feed additive for horses, pigs and ruminants (Table 1).
On 23.3.2023, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) of the European Food Safety Authority (EFSA), in its opinion on the safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) for horses, pigs and ruminants, could not conclude on the efficacy of the additive for veal calves, and, consequently, for other ruminants for fattening or rearing.
The Commission gave the possibility to the applicant to submit supplementary information and data to complete the assessment and to allow a revision of the EFSA's opinion. The new data have been transmitted by the applicant using the e‐submission food chain platform (application number FEED‐2023‐18711).
In view of the above, the Commission asks EFSA to deliver a new opinion on Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) as a zootechnical feed additive for ruminants other than for milk production based on the supplementary information and data submitted by the applicant, in accordance with Article 29(1)(a) of Regulation (EC) No 178/2002.
Additional information
1.2
The additive consists of viable cells of Saccharomyces cerevisiae DBVPG 48 SF. EFSA issued an opinion on the safety and efficacy of this product when used in feed for horses, pigs and ruminants (EFSA FEEDAP Panel, 2023). The additive is currently authorised for the use in feed for horses, dairy ruminants an pigs (4d24).2
DATA AND METHODOLOGIES
2
Data
2.1
The present assessment is based on data submitted by the applicant in the form of supplementary information3 to a previous application on the same product.4 The dossier was received on 23 October 2023 and the general information and supporting documentation are available on Open.EFSA at https://open.efsa.europa.eu/questions/EFSA‐Q‐2023‐00694.
In accordance with Article 38 of the Regulation (EC) No 178/20025 and taking into account the protection of confidential information and personal data in accordance with Articles 39 to 39e of the same Regulation, and the Decision of EFSA's Executive Director laying down practical arrangements concerning transparency and confidentiality,6 a non‐confidential version of the supplementary information has been published on Open.EFSA.
Methodologies
2.2
The approach followed by the FEEDAP Panel to assess the efficacy of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) is in line with the principles laid down in Regulation (EC) No 429/20087 and the relevant guidance documents: Guidance on the assessment of the efficacy of feed additives (EFSA FEEDAP Panel, 2018).
ASSESSMENT
3
The additive under assessment, with the trade name BioCell®, consists of viable cells of Saccharomyces cerevisiae DBVPG 48 SF and is intended to be used as a zootechnical additive in feed for ruminants (other zootechnical additives: performance enhancer).
The additive is intended to be used at the following proposed minimum use levels for:
- Dairy cows and minor dairy species: 4.0 × 10^8^ colony forming unit (CFU)/kg complete feed
- Calves, cattle for fattening and minor growing and fattening ruminants: 4.0 × 10^9^ CFU/kg complete feed
The additive was fully characterised in the previous opinion of the FEEDAP Panel (EFSA FEEDAP Panel, 2023). The FEEDAP Panel concluded that the additive is considered safe for the target species, the consumers and the environment. The additive, in any of its formulations, is not an irritant to the eyes and skin but should be considered a respiratory sensitiser. No conclusions could be drawn on the skin sensitisation potential of the additive. The FEEDAP Panel also concluded that the additive has the potential to be efficacious at the proposed conditions of use for horses, dairy ruminants and all pigs.
In that opinion, three long‐term trials were submitted aiming to demonstrate the efficacy of BioCell® on the zootechnical performance of veal calves. However, none could be further considered as evidence of the efficacy due to the high number of veterinary medical treatments administered (ranging 20%–45% of total animals) and the high mortality rates (6%–7% in the control groups).
The applicant provided three additional in vivo efficacy trials with a similar experimental design to support the efficacy of BioCell® in veal calves.
Efficacy
3.1
Three long‐term trials sharing a common design were submitted aiming at assessing the effect of the additive on the zootechnical performance of veal calves. The details on the study design are provided in Table 2 and the main results in Table 3.
■■■■■
■■■■■
■■■■■
■■■■■
Overall, the three studies showed positive effects of the supplementation with BioCell® at the proposed conditions of use on the performance of veal calves.
Conclusions on the efficacy
3.1.1
In its previous opinion, the FEEDAP Panel concluded that the additive has the potential to be efficacious for dairy ruminants at the use level of 4.0 × 10^8^ CFU/kg complete feed. Considering the results of the new studies in calves, the FEEDAP Panel concludes that the additive has the potential to be efficacious as a zootechnical additive for all ruminants at the proposed condition of use: 4.0 × 10^8^ CFU/kg complete feed for dairy ruminants and 4.0 × 10^9^ CFU/kg complete feed for ruminants for fattening and rearing.
CONCLUSIONS
4
The additive has the potential to be efficacious in feedingstuffs for all ruminants at the proposed condition of use of 4.0 × 10^8^ CFU/kg complete feed for dairy ruminants and 4.0 × 10^9^ CFU/kg complete feed for ruminants for fattening and rearing.
ABBREVIATIONSCFUcolony forming unitFEEDAPPanel on Additives and Products or Substances used in Animal FeedLOQlimit of quantification
CONFLICT OF INTEREST
If you wish to access the declaration of interests of any expert contributing to an EFSA scientific assessment, please contact [email protected].
REQUESTOR
European Commission
QUESTION NUMBER
EFSA‐Q‐2023‐00694
COPYRIGHT FOR NON‐EFSA CONTENT
EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source.
PANEL MEMBERS
Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Maryline Kouba, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Roberto Edoardo Villa and Ruud Woutersen
LEGAL NOTICE
Relevant information or parts of this scientific output have been blackened in accordance with the confidentiality requests formulated by the applicant pending a decision thereon by EFSA. The full output has been shared with the European Commission, EU Member States (if applicable) and the applicant. The blackening may be subject to review once the decision on the confidentiality requests is adopted by EFSA and in case it rejects some of the confidentiality requests.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed) , Rychen, G. , Aquilina, G. , Azimonti, G. , Bampidis, V. , Bastos, M. L. , Bories, G. , Chesson, A. , Cocconcelli, P. S. , Flachowsky, G. , Gropp, J. , Kolar, B. , Kouba, M. , López‐Alonso, M. , López Puente, S. , Mantovani, A. , Mayo, B. , Ramos, F. , Saarela, M. , … Martino, L. (2018). Guidance on the assessment of the efficacy of feed additives. EFSA Journal, 16(5), 5274. 10.2903/j. · doi ↗ · pubmed ↗
- 2EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed) , Bampidis, V. , Azimonti, G. , Bastos, M. L. , Christensen, H. , Durjava, M. , Dusemund, B. , Kouba, M. , López‐Alonso, M. , López Puente, S. , Marcon, F. , Mayo, B. , Pechová, A. , Petkova, M. , Ramos, F. , Sanz, Y. , Villa, R. E. , Woutersen, R. , Brantom, P. , … Revez, J. (2023). Scientific opinion on the safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae · doi ↗ · pubmed ↗
